MTATP6P25

Across TCGA pan-cancer cohorts, MTATP6P25 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MTATP6P25 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MTATP6P25 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MTATP6P25 expression acts as an unfavorable survival marker, although some lineages such as ACC and SKCM show a favorable association.

ACC, THYM, and BRCA are the cancer types where MTATP6P25 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Quartile	All	0.840	0.326	<.001	42	view →
THYM	DFS	Tertile	All	0.627	0.889	.002	36	view →
BRCA	OS	Tertile	IV	0.310	0.664	.016	27	view →
LUSC	DFS	Tertile	II,III,IV	0.389	0.743	.001	22	view →
SKCM	OS	Tertile	III,IV	1.000	0.340	.003	12	view →
READ	DFS	Tertile	II,III,IV	0.237	0.682	.031	12	view →
BLCA	DFS	Tertile	III,IV	0.638	0.166	.024	9	view →
DLBC	OS	Tertile	All	0.526	0.933	.024	9	view →
MESO	OS	Tertile	III,IV	0.247	0.573	.049	9	view →
ESCA	DFS	Quartile	III,IV	0.271	0.535	.016	9	view →
THCA	DFS	Tertile	III,IV	0.973	0.870	.048	3	view →
KICH	DFS	Tertile	III,IV	1.000	0.412	.031	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MTATP6P25–ACC (DFS)

Open the ACC breakdown →